ESC 365 - Optimising treatment for high-risk patients: lessons from VICTORIA

Open Access

Optimising treatment for high-risk patients: lessons from VICTORIA

Session: Pioneering advances in HFrEF management: unlocking the potential of sGC stimulation

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Professor S. Greene (Durham, US)

Sponsored by Bayer AG

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Professor Stephen Greene

Duke Clinical Research Institute, Durham (United States of America)

14 presentations

3 followers

5 more presentations in this session

Welcome and introduction

Speaker: Professor J. Butler (Dallas, US)

Dispelling the myth: are HFrEF patients ever 'stable'?

Speaker: Associate Professor M. Cikes (Zagreb, HR)

Enhancing the approach to titration: the VELOCITY trial

Speaker: Professor M. Senni (Bergamo, IT)

Advancing therapeutic options in HFrEF: the VICTOR trial

Speaker: Professor J. Butler (Dallas, US)

Expert panel discussion and Q&A

Access the full session

Pioneering advances in HFrEF management: unlocking the potential of sGC stimulation

Speakers: Professor S. Greene, Professor J. Butler, Associate Professor M. Cikes, Professor M. Senni, Professor J. Butler

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources